Kintor’s Male Hair Loss Drug Returns With Phase III Win

Kintor watches for a younger trend of hair loss in the Chinese population. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D